Uretron D/S
Active substance: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, HYOSCYAMINE SULFATE, METHYLENE BLUE, METHENAMINE
TABLET · SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 40.8 mg/1, PHENYL SALICYLATE 36.2 mg/1, HYOSCYAMINE SULFATE .12 mg/1, METHYLENE BLUE 10.8 mg/1, METHENAMINE 81.6 mg/1
United StatesActive
Marketing holder: DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · 40.8 mg/1
- PHENYL SALICYLATE · 36.2 mg/1
- HYOSCYAMINE SULFATE · .12 mg/1
- METHYLENE BLUE · 10.8 mg/1
- METHENAMINE · 81.6 mg/1
Registration
- Registration number
- 12539-144
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 12539-144 · Verified 2026-10-09 · open in source